4-MBC Banned in EU

Due to concerns about endocrine disruption, this material has, as of 1 May 2026, been banned in the EU and will be banned by the UK in January 2027. It is also currently under review by the TGA. READ MORE.

Bemotrizinol gains FDA approval

On 9 June 2026, the US FDA approved this UV active for use in sunscreen formulations at a maximum permitted level of 6% w/w. READ MORE.

ASCC Position Statement – ‘Reef Safe’

ASCC POSITION STATEMENT – “REEF SAFE” Prepared by John Staton - ASCC Technical Committee August 2019 – Updated August 2022

Fragrance Regulation Changes

European Commission & IFRA Updates

A note from the ASCC Technical Committee

4-Methylbenzylidene Camphor (4-MBC, Enzacamene, CAS No, 36861-47-9) is a UV filter active in the UVB region, with a peak absorbance at 300 nm.

Due to concerns about endocrine disruption, this material has, as of 1 May 2026, been banned in the EU and will be banned by the UK in January 2027. It is also currently under review by the TGA.

It is currently approved in Australia at a maximum level of 4% w/w.
Brands formulating for the EU market will need to ensure that their sunscreens are compliant with the new EU regulations.

4-MBC Banned in EU

4-MBC Banned in EU

Table of Contents

Bemotrizinol gains FDA approval

ASCC Position Statement – ‘Reef Safe’

Fragrance Regulation Changes

A note from the ASCC Technical Committee

Useful Links